Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study
Authors:
- 1 December 2020
- journal article
- research article
- Published by Elsevier in The Lancet Respiratory Medicine
- Vol. 8 (12) , 1192-1200
Abstract
No abstract availableKeywords
Funding Information
- Cancer Research UK
- NIHR Bristol Biomedical Research Centre
- University Hospital Southampton NHS Foundation Trust
- National Institute for Health Research
This publication has 14 references indexed in Scilit:
- Clinical Evaluation of Three Sample-to-Answer Platforms for Detection of SARS-CoV-2Journal of Clinical Microbiology, 2020
- Comparison of Abbott ID Now, DiaSorin Simplexa, and CDC FDA Emergency Use Authorization Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Individuals Diagnosed with COVID-19Journal of Clinical Microbiology, 2020
- Multicenter Evaluation of the QIAstat-Dx Respiratory Panel for Detection of Viruses and Bacteria in Nasopharyngeal Swab SpecimensJournal of Clinical Microbiology, 2020
- Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical SpecimensJournal of Clinical Microbiology, 2020
- Multicenter evaluation of the QIAstat Respiratory Panel—A new rapid highly multiplexed PCR based assay for diagnosis of acute respiratory tract infectionsPLOS ONE, 2020
- Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCREurosurveillance, 2020
- Early Oseltamivir After Hospital Admission Is Associated With Shortened Hospitalization: A 5-Year Analysis of Oseltamivir Timing and Clinical OutcomesClinical Infectious Diseases, 2018
- Impact of turnaround time on outcome with point-of-care testing for respiratory viruses: apost hocanalysis from a randomised controlled trialEuropean Respiratory Journal, 2018
- Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trialThe Lancet Respiratory Medicine, 2017
- Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant dataThe Lancet Respiratory Medicine, 2014